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A b s t r A c t
A 23-year-old female professional dancer died suddenly following physical activity. 
Routine postmortem examination failed to establish the cause of death. No cardiac 
structural abnormalities were revealed. She had a history of presyncopal episodes 
during the last two months preceding her sudden cardiac death (SCD). Following the 
proband’s death, her family was referred to our department for clinical evaluation, 
which was carried out with use of a standard protocol. All individuals underwent de-
tailed non-invasive evaluation followed by genetic testing. It was discovered that the 
proband’s uncle had been diagnosed with arrhythmogenic right ventricular cardio-
myopathy/dysplasia (ARVC/D) almost 5 years before his niece’s SCD. The proband 
was positive for a plakophilin-2 mutation and both her father and uncle had a typical 
form of the ARVC/D disease. To strengthen our diagnostic assessment an immuno-
histochemical analysis was undertaken of a myocardial sample obtained at autopsy, 
which finally pointed towards the diagnosis of ARVC/D. Probably, the mutation had 
been inherited from her paternal grandfather. Although he had never been clinically 
evaluated, and no tissue was available for genetic analysis, he had a history of SCD at 
the age of 72, thus, raising suspicion of cardiac disease.
I N t r O D U c t I O N
Sudden cardiac death (SCD) is generally defined as natural, unexpected death 
within 1 hour of the onset of symptoms.1 Nonspecific prodromal symptoms, for example 
chest pain, palpitations, or dyspnea, can be present during the days or weeks before 
cardiac arrest.2 SCD remaining unexplained after thorough postmortem investigation 
is termed unknown-cause SCD. In at least 4% of sudden death cases, a full coroner’s 
post-mortem examination, a toxicological screening and an expert cardiac autopsy 
fail to reveal any underlying cause of death.3,4 Tan et al published data from the 
comprehensive evaluation of 43 families with a high frequency of unexplained SCD.4 
Seventeen families (40%) were identified with inherited cardiac disease including 
catecholaminergic polymorphic ventricular tachycardia, long QT syndrome, Brugada 
syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular car-
diomyopathy/dysplasia (ARVC/D), stressing the importance of defining the cause of 
sPEcIAL ArtIcLE
Unit of Inherited Cardiovascular 
Diseases, First Department of 
Cardiology, Athens University Medical 
School, Hippokration Hospital, 
Athens, Greece
HOSPITAL CHRONICLES 2015, 10(3): 166–173
Address for correspondence:
Apostolos-Ilias Vouliotis, MD,  
Unit of Inherited Cardiovascular 
Diseases, Ippokration Hospital, 
Athens, Greece;  
E-mail: apostolos2091979@gmail.com
Manuscript received April 27, 2014; 
Revised manuscript received June 24, 
2015; Accepted June 30, 2015
KEy WOrDs: sudden cardiac death; 




ARVC/D = arrhythmogenic right 
ventricular cardiomyopathy/dysplasia
ECG = electrocardiogram
LBBB = left bundle branch block
PKP2= plakophilin-2
RV = right ventricle
RVOT = right ventricular outflow tract 
SAECG = signal averaged 
electrocardiography
SCD = sudden cardiac death 
VEB = ventricular ectopic beats
VT = ventricular tachycardia
Conflict of Interest: none declared 
*Presented in part at the “Athens Cardiology Update 2014” International Cardiology Symposium in Athens (April 10-12, 2014)
FAMILy SCREENING & GENETIC TESTING FOR SUDDEN DEATH
167
death for appropriate prophylaxis of family members.4 We 
herein describe the case of a young woman who died suddenly. 
Postmortem examination was unremarkable; however, further 
investigation and clinical evaluation of the family finally identi-
fied the cause of death. 
c A s E  r E P O r t
A 23-year-old female professional dancer died suddenly 
following physical activity. Routine macroscopic and micro-
scopic postmortem investigation failed to establish the cause 
of death. No cardiac structural abnormalities were revealed. 
Both left and right ventricle were deemed normal. The proband 
had a history of presyncopal episodes during the last two 
months preceding her SCD. Following her death, her family 
was referred to our department for clinical evaluation. During 
the course of clinical investigation and search for retrospective 
clinical data, an electrocardiogram (ECG) of the young woman 
taken 6 months prior to her death was reviewed; it showed 
inverted T-waves in leads V1 and V2 as well as in leads II, III 
and aVF (Fig. 1). 
Following informed consent, family members were evalu-
ated with a standard protocol. All individuals underwent de-
tailed non-invasive evaluation including clinical examination, 
12-lead resting ECG, two-dimensional (2-D) and Doppler 
echocardiography, signal-averaged electrocardiography 
(SAECG), 24-hour Holter monitoring and exercise testing.
FA m I Ly  c L I N I c A L  F I N D I N g s
The proband’s uncle was the first family member to un-
dergo clinical investigation. He admitted that he had been 
diagnosed with ARVC/D at the age of 43, almost 5 years be-
fore his niece’s SCD. Resting 12-lead ECG exhibited negative 
T-waves in leads V1 to V3 (Fig. 2A), his SAECG was positive 
for late potentials and 24-hour Holter monitoring recorded 
FIgUrE 1. 12-lead ECG of the proband, 6 months prior to her sudden death, showed inverted or flat T-waves in leads V1 and V2 as 
well as in leads II, III and aVF.
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FIgUrE 2. A) 12-lead ECG recording showing T-wave inversion in 
right precordial leads in proband’s uncle (V1-V3; indicated by black ar-
rows). b) 2-D echocardiographic imaging of the same patient, exhibit-
ing aneurysm of RV apex (white arrows) in apical four-chamber view. 
RV right ventric-le(-ular).
>1000 ventricular ectopic beats (VEBs) and episodes of non-
sustained ventricular tachycardia (VT). 2-D echocardiography 
showed an aneurysmal formation in the right ventricular (RV) 
apex (Fig. 2B). The patient fulfilled 1 major plus 3 minor 
criteria for ARVC/D diagnosis.5 During an electrophysiology 
study, sustained VT of two morphologies had been induced, 
one with left bundle branch block (LBBB) morphology with a 
superior axis and another with LBBB and an inferior axis. He 
had finally received an implantable cardioverter-defibrillator 
and had been discharged home with a diagnosis of typical 
ARVC/D. Unfortunately, the rest of the family had not been 
informed about the hereditary nature of the disease and family 
screening of first-degree relatives had not been performed.
The proband’s father had been previously undergone 
evaluation for palpitations which failed to appreciate abnor-
malities consistent with structural heart disease. At that time, 
only hypertension was diagnosed and the patient was put on 
medication. When he was reevaluated after his daughter’s 
SCD, at the age of 59, he demonstrated T-wave inversion 
in all precordial leads (Fig. 3A), abnormal late potentials, 
and >1000/day VEBs on Holter monitoring. ECG displayed 
VEBs with LBBB morphology and inferior or superior axis. 
Echocardiography revealed a left ventricle of normal size and 
function and no atrial or ventricular septal defect. The RV 
was dilated with an RV outflow tract (RVOT) of 32 mm at a 
parasternal short-axis view, alongside a dyskinetic region in 
the RVOT and postero-diaphragmatic wall (Fig. 3B). These 
findings constituted 2 major plus 2 minor diagnostic criteria 
of ARVC/D.5
Cardiac evaluation of proband’s sister, cousins and paternal 
aunt with clinical examination, 12-lead and 24-hour ambula-
tory ECG, SAECG, and 2-D echocardiography were negative.
With both her father and uncle affected by the disease, it 
seemed most likely that ARVC/D might have been the cause 
of the young woman’s SCD. However, based on the limited 
data that were available, diagnosis was borderline with 1 major 
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(family history of ARVC/D) and 1 minor (T-wave inversion in 
leads V1-V2) criteria fulfilled.5 It was obvious that we needed 
more information in order to make a more definitive diagnosis. 
Why did we start with the clinical evaluation of the fam-
ily? One reason is that there are data that familial evaluation 
in case of sudden arrhythmic death syndromes can identify 
inherited heart diseases in the majority of families.6 Indeed, 
this case of a young woman who died suddenly of unknown 
reasons led us to the clinical evaluation of her family revealing 
2 relatives, her father and uncle, who suffered from a typical 
form of ARVC/D.
Was there an indication for genetic testing? Since two 
of the proband’s surviving relatives presented with typical 
ARVC/D (Fig. 4), we proceeded to genetic testing for muta-
tions in the five most frequent disease-causing desmosomal 
genes. Mutation analysis was undertaken in the two surviving 
relatives who had phenotypic abnormalities suggestive of 
ARVC/D (targeted, clinically-guided genetic analysis) and 
in the dead woman who was suspected of having the disease. 
Following the identification of an ARVC-causative mutation in 
both her father and uncle, mutation-specific genetic testing of the 
SCD victim was strongly indicated (class I recommendation).7
g E N E t I c  t E s t I N g  r E s U L t s
Screening for plakoglobin, desmoplakin, desmoglein-2 and 
desmocollin-2 did not reveal any nucleotide changes. Screen-
FIgUrE 3. A) 12-lead rhythm strip of the proband’s father exhibiting 
negative T-waves in leads V1-V6, ventricular couplets and VEBs. b) 
Aneurysm of right ventricular postero-diaphragmatic wall in subcostal 
four-chamber view in the same patient. LA = left atrium; LV left ven-
tricle; RV = right ventricle; VEB = ventricular ectopic beats.
170
HOSPITAL CHRONICLES 10(3), 2015
ing for plakophilin-2 (PKP2), however, revealed a single-base 
deletion (2509delA). The mutation is predicted to introduce a 
number of novel amino-acid residues at the C-terminal domain 
of the protein followed by a termination codon (S837fsX930). 
Both proband’s father and uncle were carriers of this deletion, 
while the mutation was not identified in none of the other 
unaffected family members who were screened. The mutation, 
which showed 100% penetrance amongst the living family 
members, was not found in 400 control chromosomes and was 
thus considered pathogenic. 
Following the results of the genetic diagnosis, a formalin-
fixed, paraffin-embedded myocardial sample obtained from 
the proband at autopsy, was retrieved from the forensic 
medicine department and subjected to DNA extraction. The 
proband was positive for the specific mutation (Fig. 5).
I m m U N O h I s t O c h E m I s t r y
In an effort to confirm the diagnosis, a myocardial sample 
obtained from the proband at autopsy was immunostained 
using methods that have been validated in a previous study.8 
Myocardium obtained at autopsy from two age-matched indi-
viduals with no clinical history or pathological evidence of heart 
disease was subjected to the same staining protocol and used 
as controls. Primary antibodies included monoclonal mouse 
anti-plakoglobin, polyclonal rabbit anti-desmoplakin, mono-
clonal mouse anti-Pan Cadherin and monoclonal mouse anti-
plakophilin-2 antibodies. Immunostained preparations were 
analyzed by quantitative laser scanning confocal microscopy.8
To examine the effect of 2509delA on the distribution and 
expression levels of intercalated disk proteins, immunohisto-
chemistry was performed on a myocardial sample obtained 
from the proband at autopsy. Myocardium from age-matched 
autopsy subjects who had no clinical history or pathological 
evidence of heart disease was subjected to the same staining 
protocol and used as controls. ARVC/D and control myocar-
dium showed comparable levels of expression of N-cadherin, 
but there was a marked decrease in the amount of immunore-
active signal at intercalated disks for plakoglobin, desmoplakin 
and plakophilin-2 (Fig. 6).
Immunohistochemical analysis of a myocardial sample 
obtained from the proband showed significantly reduced 
expression levels of plakoglobin, plakophilin-2 and desmo-
plakin at intercalated disks. Previous studies have shown that 
plakophilin-2 binds the N-terminal domain of desmoplakin and 
recruits it to the membrane.4 This may explain the inability of 
desmoplakin to get adequately incorporated in the proband’s 
desmosomal structures in the presence of a PKP2 mutation. 
Recent immunohistochemical studies on cardiac tissue from 
patients affected by ARVC/D, demonstrated markedly de-
creased localization of plakoglobin at intercalated disks.8 In 
fact, reduced immunoreactive signal for plakoglobin at myo-
cardial cell-cell junctions has been proven to be highly specific 
and sensitive for ARVC/D rendering it a valuable diagnostic 
tool in post-mortem diagnosis of the disease, particularly when 
an expert pathological evaluation is not achievable. Immu-
nohistochemical studies for plakoglobin may also constitute 
a successful guide in family screening for ARVC/D-causing 
gene mutations.
What was the cause of death eventually? The proband 
was positive for a PKP2 mutation and both her father and 
uncle had a typical form of the disease. To strengthen our 
FIgUrE 5. Electropherograms showing wild-type (A) and mutant (b) sequences of the gene encoding plakophilin-2. The position of 
the deletion (2509delA) is marked with an arrow.
FIgUrE 4. Pedigree of the affected family. Slanted bars indicate 
deceased individuals; “+” and “-” the presence or absence of the 
plakophilin-2 mutation. The index case is marked with an arrow. 
SD = sudden death.
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diagnostic assessment, an immunohistochemical analysis 
was undertaken of a myocardial sample obtained at autopsy, 
which pointed towards ARVC/D. Moreover, tissue paraffin 
blocks from various sites of the right ventricle were sent for 
histological analysis to an expert cardiac pathologist. This 
time fibrotic areas with a patchy distribution were detected. 
Some of the tissue samples revealed extensive fibrofatty tissue 
replacement with myocardial atrophy, whereas others had a 
completely normal myocardium. Thus, her death was attrib-
uted to ARVC/D. Probably, the mutation had been inherited 
from her paternal grandfather. Although he had never been 
clinically evaluated, and no tissue was available for genetic 
analysis, he had a history of SCD at the age of 72, thus, raising 
suspicion of cardiac disease.
D I s c U s s I O N
Arrhythmogenic right ventricular cardiomyopathy/dys-
plasia (ARVC/D) has a prevalence of 1:1000 to 1:5000 in the 
general population, while in certain parts of the world it is the 
major cause of SCD in individuals ≤35 years of age.10 These 
numbers may be underestimated because wide phenotypic 
variation, age-related progression and low genetic penetrance 
may obscure the diagnosis.11
ARVC/D has an unusually prominent arrhythmogenic 
phenotype that is manifest early in the natural history of 
the disease, often preceding the development of ventricular 
remodeling or contractile dysfunction. Sometimes, SCD is 
the first manifestation. Accurate and timely diagnosis of the 
disease in its early, asymptomatic phase is, therefore, pivotal 
in preventing unexpected SCD. Individuals with an early phase 
disease are often asymptomatic, but may nonetheless be at risk 
of SCD. This phase is characterized by propensity towards 
ventricular arrhythmia in the setting of preserved morphology, 
histology, and ventricular function. As the disease progresses, 
myocyte loss, inflammation, and fibroadiposis become evident. 
Structural abnormalities range from regional wall motion 
abnormalities, ventricular aneurysms, and increased trabecula-
tions to global ventricular dilation and dysfunction.
A molecular genetics approach that would identify indi-
viduals at risk, even before the disease manifests, might be of 
help. In the absence of the victim’s detailed medical history and 
clues from the postmortem examination, it would be impossible 
to correctly “target” genetic testing. Screening for all genes 
implicated in both electrical syndromes and cardiomyopathies 
FIgUrE 6. Immunofluorescence images of control myocardium (A) and myocardium obtained from the dead proband (b). Affected 
myocardium showed diminished immunoreactive signal for plakoglobin, plakophilin-2 and desmoplakin at cardiac intercalated discs.
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would not be cost-effective and time-saving. Furthermore, in 
most inherited SCD syndromes, the success rate of genotyp-
ing is <50%.
The aim of this case report is to highlight the following 
issues: 1) The difficulties of national health care systems 
to deal with patients and families suffering from inherited 
cardiovascular diseases. An inherited heart disease diagnosis 
in a family member, or an unknown-cause SCD of a young 
person should prompt family screening which might reveal 
other family members with an early asymptomatic form of 
cardiomyopathy or channelopathy. In our case, immediate 
response would lead to a timely diagnosis of the disease, 
hence, preventing the young woman’s SCD. 2) It is crucial that 
all first-degree family members of patients with an inherited 
cardiovascular disease diagnosis to be clinically screened in 
a specialized center. Having only the medical history of the 
family and not the clinical cardiac screening from a special-
ized center may lead to misdiagnosis or delayed diagnosis, as 
it happened in the proband’s father.
ARVC is familial in almost 50% of cases and mostly 
inherited in an autosomal dominant way. Furthermore, the 
disease may exhibit an age-related progression. Penetrance 
is often incomplete and there is a phenotypic variation both 
in its presentation and clinical course, even within affected 
individuals from the same family.12 Despite thorough clinical 
investigation, a definitive diagnosis is often problematic. It 
usually rests upon fulfilling a set of major and minor criteria. 
Fulfillment of 2 major, 1 major plus 2 minor or 4 minor criteria 
is considered diagnostic.5 Clinical evaluation of the patient’s 
uncle led to diagnosis of a typical form of ARVC/D. In the 
case of the proband’s father, although examined in the past, 
examining physicians had failed to appreciate abnormalities 
consistent with ARVC/D.
SCD in a young individual should draw our attention to 
two crucial points in the realm of ARVC/D; the association of 
the disease with exercise and the possibility of fatal arrhyth-
mias developing in patients with asymptomatic forms of the 
disease. The proband was the only affected family member to 
die suddenly at such a young age, but she was also the only one 
that had been engaged in vigorous physical activity. Physical 
exercise per se is not a cause of enhanced mortality; it may 
however promote arrhythmias or speed-up disease progres-
sion in individuals already affected by a cardiac disorder.13 
The proband presumably developed VT, which subsequently 
deteriorated to ventricular fibrillation leading to her death. 
Areas of fibrofatty replacement provide an excellent substrate 
for the generation of re-entrant arrhythmias. Cardiac elec-
trical instability, however, has been shown to occur even in 
early stages of disease, prior to the development of significant 
ventricular remodeling.14
It should be noted that the proband’s father had previously 
been misdiagnosed and the proband herself had not been ad-
vised to seek further medical evaluation despite the abnormal 
ECG in combination with ARVC/D family history (her uncle). 
ARVC/D can still be missed at early stages because physicians 
are often unable to recognize or appreciate early or subtle signs 
and may have little comprehension of its hereditary nature. 
When a patient is diagnosed with a familial cardiomyopathy, 
physicians and health care systems should respond immediately 
by referring all first and second-degree relatives for clinical in-
vestigation. Referral of family members to a specialized center 
is crucial, since family history and routine cardiac evaluation 
often fail to establish a diagnosis. Clinical diagnosis of inher-
ited SCD syndromes is often impeded by phenotypic diversity 
and age-related disease progression. Most SCD victims have 
never sought medical attention prior to their death, therefore 
clinical data might be absent. ARVC/D, particularly when the 
disease initially is localized, might be misdiagnosed at autopsy.
Targeted genetic analysis has a major role when dealing 
with unknown cause sudden death families. Definitive genetic 
diagnosis in an index case offers an attractive solution by ena-
bling cascade screening of families. In a typical family with an 
autosomal dominant inheritance pattern, approximately half 
of the relatives will test gene-negative, affording them with 
permanent reassurance and obviating the need to screen their 
children. In our case, the identification of a pathogenic muta-
tion in already diagnosed typical forms of the disease (father 
and uncle of the proband) gave us the opportunity to seek 
the specific mutation in the dead proband who fulfilled only 
1 major (family history of ARVC/D) and 1 minor (inverted T 
waves in leads V1-V2) criteria, exhibiting a subclinical form 
of the disease. Genetic analysis revealed that the proband, as 
well as her father and uncle, had a mutation in PKP2.
c O N c L U s I O N
This report highlights the importance of family screening, 
not only in SCD cases, but also when an individual is diagnosed 
with an inherited disease of the heart. It also emphasizes the 
role of genetic testing in facilitating postmortem diagnosis and 
cascade screening of surviving relatives, stressing, however, 
that it should complement, not replace, clinical investigations.
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